在开始数字肌肉骨 (MSK) 计划后一年内开始服用阿片类药物:一项观察性,纵向研究与对照组
Grace Wang1, Louie Lu1, Laura S Gold2
1Clinical Research, Hinge Health, Inc, San Francisco, CA, USA.
Journal of pain research
|August 3, 2023
概括
与传统的物理治疗相比,数字化提供慢性肌肉骨疼痛的保守护理显著减少了阿片类药物启动和处方. 这种数字化方法在治疗疼痛和减少对阿片类药物的依赖方面表现有前途.
科学领域:
- 肌肉骨 (MSK) 疼痛的管理
- 数字健康干预措施 数字健康干预措施
- 减少阿片类药物的使用.
背景情况:
- 慢性肌肉骨 (MSK) 疼痛的保守护理可能会减少阿片类药物使用,但数字化提供护理的有效性尚未得到充分证实.
- 这项研究调查了数字MSK程序与阿片类药物启动和处方率在患有慢性MSK疼痛的未使用阿片类药物的成年人之间的关联.
研究的目的:
- 为了比较使用数字MSK程序和接受传统物理治疗的人之间的阿片类药物启动和处方率.
- 评估数字传递的保守护理计划对慢性MSK疼痛患者阿片类药物使用的影响.
主要方法:
- 使用商业医疗和药房索赔数据的观察性研究.
- 倾向性比分匹配比较4195个数字MSK项目成员与4195个匹配的物理治疗患者.
- 多变量回归模型控制了人口统计,并发病率和基线医疗保健利用率,以分析12个月内的阿片类药物处方.
主要成果:
- 与物理治疗患者相比,数字MSK计划成员的阿片类药物启动率明显较低 (7.89%与13.64%,p < 0.001).
- 在数字MSK组 (16.73) 与物理治疗组 (22.36) 相比,每100名参与者中观察到的阿片类药物处方较少.
- 调整后的分析显示,数字MSK计划成员的阿片类药物开始率较低 (OR:0.52),每100名参与者处方更少 (β: -6.40).
结论:
- 对于MSK疾病而言,以数字方式提供的保守护理为减少阿片类药物开始提供了一个有希望的策略.
- 这些发现表明,数字MSK计划可以成为治疗慢性MSK疼痛和减轻阿片类药物使用的传统护理的有效替代方案.
- 需要进一步的研究来证实这些发现,考虑到观察设计和共变量匹配的局限性.
更多相关视频
03:26Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
2.7K
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.7K
相关概念视频
Analgesia and Pain Management
660
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
660
Opioid Analgesics: Morphine and Other Natural Cogeners
293
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
293
Opioid Analgesics: Synthetic and Semisynthetic Opioids
336
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
336
Opioid Receptors: Overview
1.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.0K
